Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Avenue Therapeutics Inc | ATXI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.44 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.44 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 3.35 - 93.75 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 3.44 | USD |
Avenue Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 45.57M | 13.25M | - | 0 | -10.38M | -0.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Avenue Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATXI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.75 | 3.9899 | 3.35 | 3.59 | 18,853 | -0.31 | -8.27% |
| 1 Month | 4.68 | 5.97 | 3.35 | 4.11 | 104,248 | -1.24 | -26.50% |
| 3 Months | 13.3875 | 13.875 | 3.35 | 9.77 | 1,038,357 | -9.95 | -74.30% |
| 6 Months | 14.25 | 26.4675 | 3.35 | 18.18 | 3,177,908 | -10.81 | -75.86% |
| 1 Year | 81.75 | 93.75 | 3.35 | 17.97 | 2,036,159 | -78.31 | -95.79% |
| 3 Years | 5,242.50 | 5,454.225 | 3.35 | 384.20 | 1,822,234 | -5,239.06 | -99.93% |
| 5 Years | 6,232.50 | 14,130.00 | 3.35 | 733.55 | 1,144,497 | -6,229.06 | -99.94% |
Avenue Therapeutics Description
| Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and markets pharmaceutical products for the acute care setting. It focuses on developing its product candidate, an intravenous (IV) formulation of tramadol HCI (IV Tramadol), for post-operative acute pain. |
